Artemisinin: A Line From the Fourth Century

A war that needed a chemistry answer

In 1967, the Chinese government received an unusual request from Hồ Chí Minh: North Vietnamese soldiers were being killed by malaria faster than by US bullets. The standard antimalarial — chloroquine — no longer worked. The malaria parasite, Plasmodium falciparum, had evolved resistance during the previous two decades of widespread chloroquine use.

Mao Zedong launched Project 523, named for the date it was authorized (23 May). It was a secret nationwide effort to find a new antimalarial. About 500 Chinese scientists across 60 institutions were assigned.

By 1969, two years in, the project had screened over 240,000 compounds. None worked.

In January 1969, the project’s leadership transferred responsibility for the natural-products branch to a 39-year-old researcher at the Beijing Academy of Traditional Chinese Medicine named Tu Youyou (屠呦呦). She had no doctoral degree (China’s higher-education system had been disrupted by the Cultural Revolution). She had no foreign training. She had a background in both modern pharmacology and classical Chinese herbal medicine.

She was given a single instruction: find something in the herbal canon that works.

A traditional clue

Tu’s team systematically combed Chinese herbal manuals — about 2,000 traditional remedies for “fever” or “intermittent fever.” They screened over 380 plant extracts in malaria-infected mice. Most did nothing. A few worked weakly. None was a clear winner.

One extract that showed flashes of activity was from a plant called qinghao — Artemisia annua, sweet wormwood. Hot-water extracts of qinghao would sometimes reduce parasite counts by 60 or 70 percent and sometimes do nothing. The inconsistency was maddening. The team was about to discard it.

In 1971, Tu went back to the original texts. In a 4th-century manuscript by the Daoist physician and alchemist Ge Hong (葛洪, Zhouhou Beiji Fang, “Handbook of Prescriptions for Emergencies”) she found a one-line instruction for treating intermittent fever:

青蒿一握，以水二升渍，绞取汁，尽服之。 “Take a handful of qinghao, soak in two sheng of water, wring out the juice, drink it all.”

There was no boiling. Ge Hong specified cold-water extraction.

Tu immediately understood. The active compound was probably destroyed by heat. Switching from boiling water to low-temperature ether extraction, her team re-isolated the active material in October 1971.

The new extract killed 100% of malaria parasites in mice. In monkeys, the same result. The team had what every other extraction had missed.

The active compound was a small molecule, C₁₅H₂₂O₅, with an unusual structural feature: an internal peroxide bridge (two oxygen atoms covalently linked across a ring system). They named it qinghaosu in Chinese (青蒿素, literally “qinghao essence”), later renamed artemisinin in English.

A trial that worked, on someone who needed it to

By 1972, the team had pure artemisinin and a long animal-data record. But Project 523 had no human-trial infrastructure that would meet modern standards. Tu and two colleagues volunteered to take the first doses themselves to check for toxicity. They didn’t get sick.

In August 1972, the first human malaria patients received pure artemisinin in Hainan. Twenty-one patients infected with P. vivax or chloroquine-resistant P. falciparum. Twenty-one rapid recoveries. Fever broke within 24 hours. Parasite counts dropped to zero within 48 hours. No serious side effects.

This was the moment. A 4th-century one-line clue, run through 1970s Chinese pharmacology, had produced a working drug.

The work was published in Chinese scientific journals throughout the 1970s and 80s. Because of the political isolation of China during the Cultural Revolution, it was almost completely unknown in the West. The WHO didn’t seriously evaluate artemisinin until the late 1990s. It was added to the WHO essential medicines list in 2002. The first artemisinin-based combination therapies (ACTs) became standard malaria treatment globally around 2005.

In 2015, Tu Youyou was awarded the Nobel Prize in Physiology or Medicine — at age 84, the first scientist from the People’s Republic of China to win a Nobel in any science. She is also one of the few Nobel laureates ever awarded without a doctorate.

She donated her prize money to Chinese pharmacology research and has largely avoided the press.

What the peroxide bridge does

Artemisinin’s killing mechanism turned out to be unique among antimalarials. The plant-derived molecule contains an endoperoxide bridge — two oxygen atoms bonded directly to each other and embedded in the molecule’s three-dimensional framework. This is a highly unusual structural element; almost no other natural product has it.

When artemisinin enters a red blood cell parasitized by Plasmodium, the parasite is busy digesting hemoglobin. Hemoglobin contains iron (in the heme groups). The free iron, released as a digestion byproduct, reacts with artemisinin’s peroxide bridge — the iron’s electrons cleave the O–O bond and generate a highly reactive carbon-centered free radical.

The radical then attacks essential parasite proteins and membranes indiscriminately, killing the parasite within minutes.

Crucially, mammalian cells don’t generate the same iron-rich environment. Your red blood cells don’t release free iron at the rates the parasite does. Artemisinin acts as a parasite-targeted chemical bomb, triggered only by the chemistry of an actively malarial cell.

This is also why artemisinin has been so slow to develop resistance: the mechanism is so simple and so unselective that the parasite would have to evolve fundamentally different metabolism to resist it. Resistance has emerged in Southeast Asia and is a serious concern, but compared to chloroquine — which lost effectiveness within a couple of decades — artemisinin has held up for fifty years.

The lives saved

Malaria kills more people, globally, than any other infectious disease except tuberculosis. Most of the deaths are children under 5 in sub-Saharan Africa. In the 1990s, before ACT became standard, malaria killed about 900,000 children a year, plus uncounted adults.

Following the WHO rollout of ACTs starting in the mid-2000s, malaria deaths globally have dropped by about half. The World Malaria Report estimates artemisinin-based therapies have prevented somewhere between 1 and 1.5 million deaths per year. Almost all of these are children who would otherwise have died of cerebral malaria.

A 1.5-million-lives-per-year figure means that artemisinin is, by raw mortality count, the most important pharmaceutical of the 21st century. It accomplishes more good per year than any antibiotic, any antiviral, any cancer drug. It is also, per dose, one of the cheapest drugs in the global health pharmacy.

The cost of a course of ACT to treat one child with malaria is about $1 to$2.

A footnote about traditional medicine

Artemisinin’s history is sometimes used to argue for the general validity of traditional medicine — “see, Chinese herbal manuals contain real drugs that just need to be extracted properly.”

Tu Youyou’s career argues something more specific. She read 2,000 traditional recipes. Most did nothing in modern testing. One contained a real molecule, hidden by a wrong preparation method, recoverable only because she had the chemistry sophistication to recognize that “soak in cold water” implied “the active compound is heat-sensitive.”

The lesson is not that traditional medicine is valid. The lesson is that traditional medicine occasionally encodes empirical signal — accidentally, without theoretical understanding — and that signal can be extracted, when present, only by people fluent in both the tradition and modern chemistry. Tu was fluent in both. The vast majority of traditional remedies have not yielded an artemisinin equivalent despite a century of careful search. But artemisinin was real, and it was hidden in a 1,600-year-old text.

This is the strongest case for both humility about and rigorous testing of inherited medical knowledge.

A 4th-century line, in 2027

The line from Ge Hong’s manuscript — 「青蒿一握，以水二升渍，绞取汁，尽服之」 — is now carved on a memorial wall at the Tu Youyou Research Centre in Ningbo, beside the structural formula of the molecule it produced.

A single line of classical Chinese, written by a Daoist physician in the 4th century while the Roman Empire was collapsing on the other side of the world, saved hundreds of thousands of lives per year in the 21st century.

The cure for the disease that had killed more humans, cumulatively, than any other in history, was sitting in plain sight for sixteen centuries until someone with the right combination of training read the text.

---

The artemisinin molecule has its own 3D page in the library — rotate it, find the unique endoperoxide bridge that makes it a parasite-targeted radical bomb, download the structure file. It also has its own bouncing wallpaper.